The safety and efficacy of umbilical cord mesenchymal stem cell transplantation through femoral artery interventional procedure in spinal cord injury patients

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR-ONC-12002005

Enrollment

Unknown

Registered

2012-03-13

Start date

2012-04-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal cord injury

Interventions

1:umbilical cord mesenchymal stem cell transplantation through femoral artery interventional procedure

Eligibility

Sex/Gender

Male

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. the sequelae of spinal cord injury male patients, the injured segment T10-L1; 2. the assessment standards of the American Spinal Injury Association, ASIA (2000) confirmed the complete injury; 3. injured in one year or more.

Exclusion criteria

Exclusion criteria: Excluding syringomyelia formation of local spinal cord compression, tethered cord, bilateral hydronephrosis, bilateral hydroureter, urinary stones, the constitution of high sensitivity, liver and kidney function in patients with abnormal.

Design outcomes

Primary

Measure	Time frame
urodynamic test;Electrophysiology: movement and somatosensory evoked potentials;	—

Countries

China

Contacts

Public ContactYihua An

riveran@163.com+86 10 57976848

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026